These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 39274988)

  • 1. Application of a Novel UPLC-MS/MS Method for Analysis of Rivaroxaban Concentrations in Dried Blood Spot and Plasma Samples Collected from Patients with Venous Thrombosis.
    Pawlak K; Kruszyna Ł; Miecznikowska M; Karaźniewicz-Łada M
    Molecules; 2024 Aug; 29(17):. PubMed ID: 39274988
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Laboratory monitoring of rivaroxaban in Chinese patients with deep venous thrombosis: a preliminary study.
    Li Y; Du L; Tang X; Chen Y; Mei D
    BMC Pharmacol Toxicol; 2020 May; 21(1):38. PubMed ID: 32466800
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of dried blood spots as an alternative sampling strategy for 5-fluorouracil monitoring: From method development to clinical application.
    da Silva LC; Grando AP; de Baco LS; Hahn RZ; Ferreira Filho AF; Brucker N; Linden R; Antunes MV
    J Pharm Biomed Anal; 2023 Oct; 235():115539. PubMed ID: 37517245
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simultaneous monitoring of seven antiepileptic drugs by dried blood spot and dried plasma spot sampling: method validation and clinical application of a LC-MS/MS-based technique.
    Cao H; Jiang Y; Sun Q; Liu R; Li Y; Huang J
    J Pharm Biomed Anal; 2024 Jun; 243():116099. PubMed ID: 38493754
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Manual punch versus automated flow-through sample desorption for dried blood spot LC-MS/MS analysis of voriconazole.
    Martial LC; van den Hombergh E; Tump C; Halmingh O; Burger DM; van Maarseveen EM; Brüggemann RJ; Aarnoutse RE
    J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Jul; 1089():16-23. PubMed ID: 29747155
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A new dried blood spot LC-MS/MS method for therapeutic drug monitoring of palbociclib, ribociclib, and letrozole in patients with cancer.
    Poetto AS; Posocco B; Gagno S; Orleni M; Zanchetta M; Iacuzzi V; Canil G; Buzzo M; Montico M; Guardascione M; Basile D; Pelizzari G; Alberti M; Gerratana L; Puglisi F; Toffoli G
    J Chromatogr B Analyt Technol Biomed Life Sci; 2021 Nov; 1185():122985. PubMed ID: 34700133
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A simple and sensitive HILIC-based UHPLC-MS/MS method for quantifying of rivaroxaban in dried blood spots: Application in comparison with the plasma sample method.
    Iqbal M; Ullah Z; Ezzeldin E; Khalil NY; Al-Shakliah NS; Alrasheed A; Ahmad I; Albehlal L
    J Pharm Biomed Anal; 2021 May; 198():114023. PubMed ID: 33744464
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determination of rivaroxaban, apixaban and edoxaban in rat plasma by UPLC-MS/MS method.
    Zhang WL; Lou D; Zhang DT; Zhang Y; Huang HJ
    J Thromb Thrombolysis; 2016 Aug; 42(2):205-11. PubMed ID: 27116356
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Simultaneous Determination of Rivaroxaban and Enalapril in Rat Plasma by UPLC-MS/MS and Its Application to A Pharmacokinetic Interaction Study.
    Zheng S; Luo SB; Mei YB; Guo J; Tong LJ; Zhang Q; Ye XY
    Eur J Drug Metab Pharmacokinet; 2019 Apr; 44(2):229-236. PubMed ID: 30151746
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Developing LC-MS/MS methods to quantify rivaroxabanin human plasma and urine: Application to therapeutic drug monitoring.
    Zheng X; Chen C; Gao H; Sun X; Zhang Y; Shi J; Han X
    Biomed Chromatogr; 2022 May; 36(5):e5306. PubMed ID: 34967030
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dried-Blood-Spot Technique to Monitor Direct Oral Anticoagulants: Clinical Validation of a UPLC-MS/MS-Based Assay.
    Foerster KI; Huppertz A; Meid AD; Müller OJ; Rizos T; Tilemann L; Haefeli WE; Burhenne J
    Anal Chem; 2018 Aug; 90(15):9395-9402. PubMed ID: 29985592
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determination of docetaxel in dried blood spots by LC-MS/MS: Method development, validation and clinical application.
    Raymundo S; Muller VV; Andriguetti NB; Tegner M; Artmann AC; Kluck HM; Franzoi MA; Vilela RMM; Schwartsmann G; Linden R; Antunes MV
    J Pharm Biomed Anal; 2018 Aug; 157():84-91. PubMed ID: 29775811
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and validation of an analytical method using UPLC-MS/MS to quantify everolimus in dried blood spots in the oncology setting.
    Knapen LM; Beer Y; Brüggemann RJM; Stolk LM; Vries F; Tjan-Heijnen VCG; Erp NPV; Croes S
    J Pharm Biomed Anal; 2018 Feb; 149():106-113. PubMed ID: 29112898
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Simultaneous determination of fluoxetine and norfluoxetine in dried blood spots using high-performance liquid chromatography-tandem mass spectrometry.
    da Silva ACC; Raasch JR; Vargas TG; Peteffi GP; Hahn RZ; Antunes MV; Perassolo MS; Linden R
    Clin Biochem; 2018 Feb; 52():85-93. PubMed ID: 28987790
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Application of the isoniazid assay in dried blood spots using the ultra-performance liquid chromatography-tandem mass spectrometry.
    Lee K; Jun SH; Choi MS; Song SH; Park JS; Lee JH; Park KU; Song J
    Clin Biochem; 2017 Oct; 50(15):882-885. PubMed ID: 28427917
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Standardization and validation of a novel UPLC-MS/MS method to quantify first line anti-tuberculosis drugs in plasma and dried blood spots.
    Herrera-Pérez IG; Rodríguez-Báez AS; Ortiz-Álvarez A; Velarde-Salcedo R; Arriaga-García FJ; Rodríguez-Pinal CJ; Romano-Moreno S; Milán-Segovia RDC; Medellín-Garibay SE
    J Chromatogr B Analyt Technol Biomed Life Sci; 2023 Aug; 1228():123801. PubMed ID: 37453389
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determination of polymyxin B in dried blood spots using LC-MS/MS for therapeutic drug monitoring.
    Huang X; Liu X; Wang Y; Zhang J
    J Chromatogr B Analyt Technol Biomed Life Sci; 2022 Mar; 1192():123131. PubMed ID: 35149368
    [TBL] [Abstract][Full Text] [Related]  

  • 18. From "wet" matrices to "dry" blood spot sampling strategy: a versatile LC-MS/MS assay for simultaneous monitoring caffeine and its three primary metabolites in preterm infants.
    Dai HR; Guo HL; Wang WJ; Shen X; Cheng R; Xu J; Hu YH; Ding XS; Chen F
    Clin Chem Lab Med; 2024 Jan; 62(1):97-110. PubMed ID: 37435827
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical Validation of a Dried Blood Spot Assay for 8 Antihypertensive Drugs and 4 Active Metabolites.
    Peeters LEJ; Feyz L; Hameli E; Zwart T; Bahmany S; Daemen J; van Gelder T; Versmissen J; Koch BCP
    Ther Drug Monit; 2020 Jun; 42(3):460-467. PubMed ID: 31593031
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analytical and clinical validation of an LC-MS/MS method for carbamazepine, lamotrigine and levetiracetam in dried blood spots.
    Besten-Bertholee DD; Wegner I; Touw DJ; Ter Horst PGJ
    Eur J Hosp Pharm; 2024 Aug; 31(5):450-454. PubMed ID: 36894298
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.